Literature DB >> 15839891

The ins and outs of HIV replication.

Candace Gomez1, Thomas J Hope.   

Abstract

The life cycle of HIV-1 involves a series of steps necessary for the successful infection of human target cells. First the RNA genome enters the cytoplasm after the fusion of the viral membrane and that of the target cell. The RNA genome is then converted to DNA form through the process of reverse transcription. The DNA genome is then integrated into the host cell DNA. Next, viral proteins and more copies of the viral genome are produced. These components assemble to form new virions that are then able to propagate. The cellular proteins involved in HIV-1 entry have been known for more than a decade now and the study of the cellular and viral components involved in HIV-1 entry has led to the development of many therapeutic strategies and drugs designed to block viral replication. Recently, there have been significant advances in the understanding of HIV-1 assembly as a consequence of the identification of the cellular factors that mediate this process. This review will provide a basic outline of the current understanding of HIV-1 entry and exit.

Entities:  

Mesh:

Year:  2005        PMID: 15839891     DOI: 10.1111/j.1462-5822.2005.00516.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  19 in total

Review 1.  The structural biology of HIV assembly.

Authors:  Barbie K Ganser-Pornillos; Mark Yeager; Wesley I Sundquist
Journal:  Curr Opin Struct Biol       Date:  2008-04-09       Impact factor: 6.809

Review 2.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

3.  Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells.

Authors:  Candace Y Gomez; Thomas J Hope
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection.

Authors:  Leslie W Chinn; Minzhong Tang; Bailey D Kessing; James A Lautenberger; Jennifer L Troyer; Michael J Malasky; Carl McIntosh; Gregory D Kirk; Steven M Wolinsky; Susan P Buchbinder; Edward D Gomperts; James J Goedert; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2010-12-15       Impact factor: 5.226

Review 5.  Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection.

Authors:  Esaki M Shankar; Vijayakumar Velu; Adeeba Kamarulzaman; Marie Larsson
Journal:  World J Virol       Date:  2015-02-12

6.  Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.

Authors:  Yiming Zhong; Amy J Johnson; John C Byrd; Jason A Dubovsky
Journal:  Postdoc J       Date:  2014-06

Review 7.  Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.

Authors:  Julie A Readinger; Kristen L Mueller; Ana M Venegas; Reiko Horai; Pamela L Schwartzberg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1.

Authors:  Jeffrey H Ringrose; Rienk E Jeeninga; Ben Berkhout; Dave Speijer
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

9.  GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.

Authors:  Alenka Jejcic; Stefan Höglund; Anders Vahlne
Journal:  Retrovirology       Date:  2010-03-15       Impact factor: 4.602

10.  Small molecule targets Env for endoplasmic reticulum-associated protein degradation and inhibits human immunodeficiency virus type 1 propagation.

Authors:  Alenka Jejcic; Robert Daniels; Laura Goobar-Larsson; Daniel N Hebert; Anders Vahlne
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.